⌘K

Home/Filings/4/0000875320-25-000204

4//SEC Filing

Arbuckle Stuart A 4

Accession 0000875320-25-000204

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 4:16 PM ET

Size

5.2 KB

Accession

0000875320-25-000204

Insider Transaction Report

Form 4

Period: 2025-07-01

VERTEX PHARMACEUTICALS INC / MAVRTX

Arbuckle Stuart A

EVP\Chief Commercial Officer

Transactions

Tax Payment
Common Stock
2025-07-01$450.23/sh−37,243$16,767,916→ 63,368 total

Holdings

Common Stock
(indirect: By 401(k))
140

Documents

1 file

4
wk-form4_1751487400.xmlPrimary
FORM 4

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001557290

Filing Metadata

Form type: 4
Filed: Jul 1, 8:00 PM ET
Accepted: Jul 2, 4:16 PM ET
Size: 5.2 KB

View on SEC.gov